Background/objectives: C-reactive protein (CRP) is the most extensively studied inflammatory risk marker, and elevated serum CRP concentrations in pregnant women are known to be associated with subsequent development of preeclampsia and preterm delivery. Researchers have suggested that folate intake may help to control the inflammation process. We examined whether folate nutrition modifies the relationship between serum CRP concentration and gestational age at delivery. Subjects/methods: Serum CRP concentrations were analyzed in 815 pregnant women between 12 and 28 weeks of gestation. Dietary intakes were assessed using a 24-h dietary recall. The serum folate and high-sensitivity CRP concentrations were analyzed by radioassay and latex agglutination tests, respectively. Results: Serum CRP concentration was negatively correlated (Po0.001) with gestational age at delivery. Serum folate concentration was negatively correlated (Po0.01) with serum CRP concentration, and total dietary folate intake was positively correlated (Po0.001) with serum folate concentration. Multiple regression analysis after adjustment for covariates revealed that maternal CRP concentrations were negatively associated with gestational age at delivery; these negative associations existed only when folate intake during pregnancy was below the Korean estimated average requirements (520 mg dietary folate equivalent per day), and serum folate concentrations were above the normal (6 ng/ml). Conclusions: We found that adequate maternal folate intake during pregnancy may have a beneficial role against shorter gestational age at delivery, which is associated with higher serum CRP concentrations in pregnant women.
Introduction
C-reactive protein (CRP) is a reactant involved in the acute-phase response and rapidly increases in the presence of infection or inflammation (Kushner and Rzewnicki, 1999) . CRP production is stimulated by the release of proinflammatory cytokines, including interleukin-1, interleukin-6 and tumor necrosis factor-a (Kolb-Bachofen, 1991; Jupe, 1996) . Many researchers have reported that pregnancy induces the inflammation process (Picklesimer et al., 2008) . Systemic inflammation has been implicated in the pathogenesis of adverse pregnancy outcomes (Wolf et al., 2001) . Preterm birth, preeclampsia, pregnancy loss and adverse neonatal outcomes have all been associated with inflammatory responses (Elovitz, 2006) .
Pregnancy is associated with a marked acceleration in folate-dependent one-carbon transfer reactions, including those required for nucleotide synthesis, and thus, cell division, which is the basis for the substantial increase in folate requirements during pregnancy (Bailey, 1995; Tamura and Picciano, 2006) . The increase in cell division is associated with the rapidly growing fetus and placenta, and in addition, to an expansion in the number of maternal red cells and the size of the reproductive organs (Cunningham et al., 1993) . Thus, it is clear that these folate-dependent reactions are essential for fetal growth and development and for maternal and paternal well-being. Inadequate folate intake and low serum folate concentrations have been associated with poor pregnancy outcomes (Scholl et al., 1996; Tamura and Picciano, 2006) .
There is some evidence that a deficiency or lack of folate intake significantly alters the immune response (Dhur et al., 1991; Courtemanche et al., 2004) . Folate is related to lower concentrations of inflammatory markers and oxidative stress (Graham and O'Callaghan, 2000; Nanri et al., 2007) . The beneficial effects of folate, such as lowering blood cholesterol, reducing blood pressure, decreasing platelet aggregation, and the scavenging of free radicals and reactive oxygen species, are associated with a reduction in inflammatory markers (Holt et al., 2009) . A recent study showed that folate intake was inversely associated with CRP (Bertran et al., 2005) . This population-based study among men and women in Spain showed that higher folate intake, in addition to other known constitutive and lifestyle factors, was significantly associated with lower serum CRP concentrations. It was also reported that concentrations of plasma pyridoxal 5 0 -phosphate, an active form of vitamin B 6 , were negatively associated with CRP concentrations (Friso et al., 2001 (Friso et al., , 2004 . It is possible that dietary intakes of folate and other B vitamins have an affect on the inflammation process, and increased intake of these nutrients aid health and nutrition promotion to prevent adverse pregnancy outcomes. To our knowledge, no studies have been conducted to investigate the effects of folate and other B vitamin nutritional status on CRP concentrations in pregnant women. Therefore, the aim of this study was to determine whether folate and other B vitamins modify the relationship between serum CRP concentrations and gestational age at delivery in healthy Korean normal pregnant women.
Subject and methods
Study subjects and data collection This research was a part of the Mothers and Children's Environmental Health study, which is a multicenter (Seoul, metropolitan area; Ulsan, industrial area; and Cheonan, medium size urban area) prospective cohort study in South Korea. Comprehensive information about the study is available elsewhere (Kim et al., 2009 ). The study sample comprised pregnant women at mid-pregnancy (for example, 12-28 weeks of gestation) of a normal (not-at-risk) pregnancy who were willing to participate after receiving written information about the study. A total of 1610 pregnant women were recruited from August 2006 to October 2009, and 25 subjects who delivered twins and 22 subjects who have a miscarriage and 26 subjects with pregnancy complications (hypertension or diabetes) were excluded. Of the subsequent 1537 pregnant women, 473 subjects who had not yet delivered babies were excluded. Among the remaining 1064 subjects, 81 without dietary intake data and 168 without serum CRP or folate concentrations at mid-pregnancy were excluded. Therefore, 815 subjects were finally included in the analysis. The study protocols and consent forms were approved by the three institutional review boards at the Ewha Womans University School of Medicine, the Dankook University Hospital and the Ulsan University Hospital. All subjects provided informed consent to participate in the study, and they were interviewed by trained interviewers. Blood samples were collected and dietary questionnaires were administered on the same day (Kim et al., 2010) .
General information on demographic factors, socioeconomic factors and health-related behaviors, including use of folic acid (pteroylglutamic acid) supplementations, was collected. The subjects were followed until delivery. Further information on pregnancy outcomes, such as gestational age at delivery (weeks), neonatal gender, birth weight (g) and birth height (cm), was obtained from the medical records. Gestational age at delivery was counted from the last menstrual period and examined by ultrasound.
Dietary assessment
Dietary data were collected by one 24-h recall for intake 1 day before blood sampling. For the 24-h recall method, experienced, well-trained dietary interviewers instructed the respondents to recall and describe all the foods and beverages they had consumed over the past 24 h. The food items most frequently eaten were made as models in a defined unit and were shown to the subjects to help them report with more accuracy. The subjects' dietary intakes of nutrients were assessed using a computerized nutrient intake assessment software program (CAN-Pro 3.0, Korean Nutrition Society, Seoul, Korea). Information regarding brand names of dietary supplements and frequencies of the consumption was collected from the subjects who took dietary supplements. Daily nutrient intakes from dietary supplements were calculated by using frequencies and nutrient contents of the supplements. Dietary folate equivalent (DFE) was calculated based on that 1.0 mg DFE is 1.0 mg of food folate or 0.6 mg of folic acid added to foods (Institute of Medicine, 2000) . Folate and other B vitamin intake data, including supplements, were compared with the estimated average requirements (EARs) of Korean dietary reference intake (The Korean Nutrition Society, 2005).
Serum folate and CRP measurements
Maternal blood samples were drawn into evacuated tubes after overnight fasting by a trained technician or nurse using standard venipuncture. Blood samples were protected from ultraviolet light, kept on wet ice and processed within 20 min of venipuncture. Serum separated into cryovials were frozen at À70 1C and placed in an ice cooler before being sent Association of folate nutrition and CRP levels with gestational age at delivery H Kim et al to a biorepository center at the Blood Bank Laboratory of NeoDIN Medical Institute (Seoul, Korea) for analysis.
Serum folate concentrations were measured by a radioassay (MP Biomedicals, Organgeburg, NY, USA). Radioactivity was measured with a g-counter (model no. 1470, Wizard, PerkinElmer, Finland). The coefficient of variation using pooled serum was reported to be 4.1% by the manufacturer. The detection limit of the assay for folate was 0.5 ng/ml. Serum folate concentrations were compared with the reference value for adequate folate status (deficiency, o3 ng/ml; borderline deficiency, 3-6 ng/ml; normal, 46 ng/ml; García-Casal et al., 2005.) The high-sensitivity CRP concentrations of the maternal serum samples were measured with latex agglutination tests performed according to the manufacturer's instructions (SS-type Pureauto S CRP latex Reagent, Sekisui, Japan and Hitachi model 7180 automated analyzer, Hitachi, Japan) using undiluted serum. The limit of detection for CRP in the serum was 0.03 mg per 100 ml.
Statistical analysis
The data are expressed as mean±s.d. values (continuous variables) or as numbers and percentages (categorical variables). The serum folate and CRP concentrations and nutrient intakes were log-transformed to normalize the distributions. Subjects were divided into two groups according to their levels of total dietary folate intake (EAR, 520 mg DFE per day) or serum folate concentrations (normal, 6 ng/ml). Correlations between nutritional status of folate and other B vitamins, serum CRP concentrations and gestational age at delivery were analyzed by Pearson's correlation test. The relationship between serum CRP concentrations in the subjects and gestational age at delivery by folate and other B vitamin nutritional status was tested in the multiple regression analysis after controlling for potential confounders, including age (Pitiphat et al., 2005) , pre-pregnancy body mass index (Pitiphat et al., 2005; Catov et al., 2007) , level of education (Imhof et al., 2001) , local centers (de Carvalho and Gomes, 2005) , neonatal gender (Kitajima et al., 2001) , urinary cotinine concentrations (Bazzano et al., 2003) and gestational age at blood collection (Tamura and Picciano, 2005; Catov et al., 2007) . The statistical analyses were performed with the SPSS statistical package (version 12.0, SPSS, Chicago, IL, USA). All reported probability tests were two-sided and the differences were considered significant at the 5% level.
Results

Study population characteristics
The participants had a mean age of 30.1 ± 3.6 years and a pre-pregnancy body mass index of 21.7±3.3 kg/m 2 (Table 1) .
About 47.4% of the pregnant women took folic acid supplements. The average folate intakes from foods and both food and supplements were 233.5±105.2 mg DFE (range 40.1-809.7 mg DFE) and 704.3 mg DFE (range 50.9-3344.9 mg DFE), respectively: the 56.6% of our subjects did not meet the EAR for folate during pregnancy (520 mg DFE per day). The mean serum folate concentration was 10.9±7.6 ng/ml: 73.6% of participants had a normal serum folate concentration (X6 ng/ml) and 4.3% had a serum folate deficiency (o3 ng/ml). The average serum CRP concentration was 0.32 ± 0.55 mg per 100 ml. The included subjects did not differ from those excluded in terms of general information or nutrient intake (data not shown).
Relationship between folate intake, CRP concentration and gestational age at delivery Serum CRP concentration was negatively correlated (Po0.001) with gestational age at delivery (Table 2 ). Serum Association of folate nutrition and CRP levels with gestational age at delivery H Kim et al folate concentration was negatively correlated (Po0.01) with serum CRP concentration, and total dietary folate intake was positively correlated (Po0.001) with serum folate concentration. Serum CRP concentrations did not differ because of the use of folic acid supplements (data not shown).
As shown in Table 3 , multiple regression analysis after adjustment for maternal age, pre-pregnancy body mass index, level of education, local centers, neonatal gender, urinary cotinine concentration, gestational age at blood collection and energy intake revealed a negative association between serum CRP concentrations and gestational age at delivery, and the association still existed when after including serum folate or total folate intake. The negative association only existed when total dietary folate intake was below the EAR (Table 4 ) and recommended intake (600 mg DFE; data not shown), and serum folate concentrations were above the normal (6 ng/ml). We found that vitamin B 6 intake o1.2 mg per day had a significant effect on the association between CRP concentration and gestational age at delivery, and the whole range of vitamin B 2 intakes had a significant effect on the association (Table 4) .
Discussion
To our knowledge, no studies have demonstrated the relation between maternal serum folate and serum CRP during pregnancy. In this study, we found that serum folate concentration was negatively correlated with serum CRP concentration, and total dietary folate intake was positively correlated with serum folate concentration. In agreement with our study, many researchers have reported that serum folate concentrations were positively correlated with dietary folate intake in pregnant women (Järvenpää et al., 2007; Matsuzaki et al., 2008) . This finding is consistent with previously reported data showing inverse associations between serum CRP and folate intake in non-pregnant subjects (Bertran et al., 2005; Holt et al., 2009) . A recent cross-sectional study of adolescents in Sweden demonstrated that folate intake was inversely associated with CRP and F 2 -isoprostanes (Holt et al., 2009) . A population-based study in Spain showed that higher folate intake, in addition to other known constitutive and lifestyle factors, was significantly associated with lower serum CRP concentrations (Bertran et al., 2005) . These results suggest that folate intake may help controlling the acute-phase reactions.
In this study, we found a negative association between maternal CRP concentration during pregnancy and gestational age at delivery. Several investigators have noted that the association between maternal CRP concentration during the first trimester and the risk of preterm delivery ( Hvilsom et al., 2002; Pitiphat et al., 2005; Catov et al., 2007; Lohsoonthorn et al., 2007) . To our knowledge, only one study has been performed to examine the relationship between the risk of preterm delivery and CRP concentration during the second trimester of pregnancy, which is the same period of blood collection as in our study, where they found no relationship between circulating CRP concentrations and preterm delivery (Ghezzi et al., 2002) . We also found that the negative associations between maternal serum CRP concentrations and gestational age at delivery only existed when total dietary folate intake was below the EAR. These results suggest that the association between serum CRP concentration and gestational age at delivery was modified by maternal folate intake. A possible explanation for this observation is that folate possesses antiinflammatory action by suppressing superoxide generation and enhancing nitric oxide production (Das, 2003) . Several investigators have noted that folate and folic acid suppress superoxide production, and prolong a half-life of nitric oxide (Loscalzo, 1996; Das, 2001; Rossi et al., 2004) . Verhaar et al. (1998) demonstrated that folic acid restored and attenuated endothelial dysfunction, and endothelial dysfunction has been postulated to be part of an exaggerated maternal inflammatory response in pregnancy (Redman et al., 1999) . In addition, cross-sectional analyses indicate that CRP is strongly correlated with markers of endothelial activation and dysfunction (Yudkin et al., 1999) . Despite the lack of a pathophysiological explanation for associations between folate and markers of the acute-phase response, a plausible interpretation of our data is that folate functions as a certain factor for inflammation-related functions. Because folate is integrally involved in the synthesis of nucleic acids and consequently in mRNA and protein synthesis, the production of cytokines and other polypeptide mediators during the inflammatory response might require increased use of folate. Another potentially important explanation for this could be that homocysteine, regulated by folate status, can promote the synthesis of proinflammatory mediators as described below.
Folate is involved in homocysteine metabolism and regulates circulating homocysteine concentrations. Several groups of investigators, including our own, have reported an inverse association between homocysteine and folate concentration in pregnant women (Guerra-Shinohara et al., 2002; Kim et al., 2004; Park et al., 2004; Lindblad et al., 2005) . Elevated plasma homocysteine during pregnancy has been implicated in placental vascular changes in preeclampsia (de Vries et al., 1997) . Although the relationships between inflammation and homocysteine metabolism are conflicting (Rohde et al., 1999; Friso et al., 2001; Folsom et al., 2003; Ravaglia et al., 2004) , a weak association between CRP and homocysteine concentrations was observed in participants of the Framingham Heart Study (Friso et al., 2001) , and in apparently healthy men in the Physicians' Health Study (Rohde et al., 1999) . Conversely, inflammatory markers were not associated with plasma homocysteine concentrations in healthy middle-aged adults from the Atherosclerosis Risk in Communities Study (Folsom et al., 2003) and in the healthy elderly men and women (Ravaglia et al., 2004) .
In our study, the negative associations between maternal serum CRP concentrations and gestational age at delivery only existed when serum folate concentrations were above the normal cutoff (6 ng/ml, Table 4 ). At present, we do not know the mechanistic explanation for these contradicting findings. One possible explanation is that serum folate concentrations may not be a reliable indicator to reflect a long-term dietary folate intake as the erythrocyte folate concentrations do. Furthermore, dietary assessment of folate intake may not be accurate. Another possibility is that our subjects already had appropriate folate status based on the fact that only 25% of subjects had serum folate o6 ng/ml.
To examine whether the negative association between CRP concentration and gestational age at delivery appeared because of other nutrients related to folate metabolism, we also analyzed vitamins B 2 and B 6 intakes. Similar results as that for folate intake were obtained for maternal vitamin B 6 intake. Bertran et al. (2005) reported that riboflavin intake was not related to serum CRP concentrations, but higher CRP concentrations were associated with lower intakes of pyridoxine. On the other hand, several studies have shown that plasma pyridoxal 5 0 -phosphate concentrations were negatively associated with CRP concentrations (Friso et al., 2001 (Friso et al., , 2004 ). Although we did not measure blood concentrations of vitamins B 2 and B 6 , our results indicate that vitamin B 6 intake o1.2 mg per day had a significant effect on the association between CRP concentration and gestational age at delivery, and the whole range of vitamin B 2 intakes had a significant effect on the association (Table 4) .
The limitations of our study include the following. First, information on current infection, which would increase CRP levels, was unavailable or incomplete for study subjects. Second, we did not obtain the data on blood concentrations of homocysteine and B vitamins (for example, pyridoxal 5 0 -phosphate and vitamin B 2 ). Third, we depended on the collection of maternal dietary intake data only from a 24-h recall, which may be less dependable than the 3-day dietary recall. However, our dietary interviewers were well-trained, which minimized potential errors in assessing dietary intakes. Nonetheless, our study had certain strengths. This study is the first to provide evidence of a relationship between maternal folate status and CRP concentration with respect to the gestational age at delivery in uncomplicated pregnant women. Our sample size was large, and this project was a part of a large-scale, multicenter, prospective study in South Korea; therefore, our data may be extrapolated to other population of Korean women as well as populations worldwide.
In conclusion, we found that adequate maternal folate intake during pregnancy may have a beneficial role against a decrease in gestational age at delivery, which is associated with increased serum CRP concentrations in pregnant women. The findings of this study also suggest there is a potential relationship between folate metabolism and the inverse association of CRP concentration with gestational age at delivery. Further studies are warranted to explore this relationship among pregnant women of poor folate status in countries where a national folic acid food fortification program has not been implemented, or where folic acid supplement use is uncommon. Also, large-scale long-term intervention studies are required to determine whether the improvement in folate status by increased folate intake or folic acid supplementation is associated with low CRP concentrations, which may lead to the prolonged gestational age at delivery.
